These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 28485375)

  • 1. Impact of NADPH oxidase functional polymorphisms in acute myeloid leukemia induction chemotherapy.
    Megías-Vericat JE; Montesinos P; Herrero MJ; Moscardó F; Bosó V; Rojas L; Martínez-Cuadrón D; Rodríguez-Veiga R; Sendra L; Cervera J; Poveda JL; Sanz MÁ; Aliño SF
    Pharmacogenomics J; 2018 Apr; 18(2):301-307. PubMed ID: 28485375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of ABC single nucleotide polymorphisms upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia.
    Megías-Vericat JE; Montesinos P; Herrero MJ; Moscardó F; Bosó V; Rojas L; Martínez-Cuadrón D; Hervás D; Boluda B; García-Robles A; Rodríguez-Veiga R; Martín-Cerezuela M; Cervera J; Sendra L; Sanz J; Miguel A; Lorenzo I; Poveda JL; Sanz MÁ; Aliño SF
    Leuk Lymphoma; 2017 May; 58(5):1197-1206. PubMed ID: 27701910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of cytarabine metabolic pathway polymorphisms in acute myeloid leukemia induction treatment.
    Megías-Vericat JE; Montesinos P; Herrero MJ; Moscardó F; Bosó V; Martínez-Cuadrón D; Rojas L; Rodríguez-Veiga R; Boluda B; Sendra L; Cervera J; Poveda JL; Sanz MÁ; Aliño SF
    Leuk Lymphoma; 2017 Dec; 58(12):2880-2894. PubMed ID: 28573946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NADPH oxidase complex and IBD candidate gene studies: identification of a rare variant in NCF2 that results in reduced binding to RAC2.
    Muise AM; Xu W; Guo CH; Walters TD; Wolters VM; Fattouh R; Lam GY; Hu P; Murchie R; Sherlock M; Gana JC; ; Russell RK; Glogauer M; Duerr RH; Cho JH; Lees CW; Satsangi J; Wilson DC; Paterson AD; Griffiths AM; Silverberg MS; Brumell JH
    Gut; 2012 Jul; 61(7):1028-35. PubMed ID: 21900546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Ras-related C3 botulinum toxin substrate 2 (Rac2), NADPH oxidase and reactive oxygen species in diallyl disulphide-induced apoptosis of human leukaemia HL-60 cells.
    Yi L; Ji XX; Tan H; Lin M; Tang Y; Wen L; Ma YH; Su Q
    Clin Exp Pharmacol Physiol; 2010 Dec; 37(12):1147-53. PubMed ID: 20804509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of novel polymorphisms related to cytotoxicity of cytarabine in the induction treatment of acute myeloid leukemia.
    Megías-Vericat JE; Montesinos P; Herrero MJ; Moscardó F; Bosó V; Martínez-Cuadrón D; Poveda JL; Sanz MÁ; Aliño SF
    Pharmacogenet Genomics; 2017 Jul; 27(7):270-274. PubMed ID: 28570300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of
    Zhang TP; Li R; Huang Q; Pan HF; Ye DQ; Li XM
    J Immunol Res; 2020; 2020():8528976. PubMed ID: 33145364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of polymorphisms in anthracyclines metabolism genes in the standard induction chemotherapy of acute myeloid leukemia.
    Megías-Vericat JE; Martínez-Cuadrón D; Herrero MJ; Rodríguez-Veiga R; Solana-Altabella A; Boluda B; Ballesta-López O; Cano I; Acuña-Cruz E; Cervera J; Poveda JL; Sanz MÁ; Aliño SF; Montesinos P
    Pharmacogenet Genomics; 2021 Aug; 31(6):133-139. PubMed ID: 33675324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of anthracycline-related cardiac histological lesions with NADPH oxidase functional polymorphisms.
    Cascales A; Pastor-Quirante F; Sánchez-Vega B; Luengo-Gil G; Corral J; Ortuño-Pacheco G; Vicente V; de la Peña FA
    Oncologist; 2013; 18(4):446-53. PubMed ID: 23576480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of combinations of single-nucleotide polymorphisms of anthracycline transporter genes upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia.
    Megías-Vericat JE; Martínez-Cuadrón D; Herrero MJ; Rodríguez-Veiga R; Solana-Altabella A; Boluda B; Ballesta-López O; Cano I; Acuña-Cruz E; Cervera J; Poveda JL; Sanz M; Aliño SF; Montesinos P
    Leuk Lymphoma; 2021 Mar; 62(3):659-668. PubMed ID: 33135528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of NADPH oxidase polymorphisms with anthracycline-induced cardiotoxicity in the RICOVER-60 trial of patients with aggressive CD20(+) B-cell lymphoma.
    Reichwagen A; Ziepert M; Kreuz M; Gödtel-Armbrust U; Rixecker T; Poeschel V; Reza Toliat M; Nürnberg P; Tzvetkov M; Deng S; Trümper L; Hasenfuss G; Pfreundschuh M; Wojnowski L
    Pharmacogenomics; 2015; 16(4):361-72. PubMed ID: 25823784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between the CYBA and NOX4 genes of NADPH oxidase and its relationship with metabolic syndrome in non-alcoholic fatty liver disease in Brazilian population.
    Rabelo F; Stefano JT; Cavaleiro AM; Lima RVC; de Campos Mazo DF; Carrilho FJ; Correa-Giannella ML; Oliveira CP
    Hepatobiliary Pancreat Dis Int; 2018 Aug; 17(4):330-335. PubMed ID: 30087027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the host pharmacogenetic background for prediction of outcome and toxicity in diffuse large B-cell lymphoma treated with R-CHOP21.
    Rossi D; Rasi S; Franceschetti S; Capello D; Castelli A; De Paoli L; Ramponi A; Chiappella A; Pogliani EM; Vitolo U; Kwee I; Bertoni F; Conconi A; Gaidano G
    Leukemia; 2009 Jun; 23(6):1118-26. PubMed ID: 19448608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relationships between the gene polymorphisms of drug metabolizing enzymes and the outcome of the first induction chemotherapy in patients with de novo acute myeloid leukemia].
    Wang N; Han JL; Mi YC; Xiao ZJ; Feng SZ; Zhou YL; Wang JX; Han MZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Apr; 19(2):327-31. PubMed ID: 21518482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A functional polymorphism in the NAD(P)H oxidase subunit CYBA is related to gene expression, enzyme activity, and outcome in non-Hodgkin lymphoma.
    Hoffmann M; Schirmer MA; Tzvetkov MV; Kreuz M; Ziepert M; Wojnowski L; Kube D; Pfreundschuh M; Trümper L; Loeffler M; Brockmöller J;
    Cancer Res; 2010 Mar; 70(6):2328-38. PubMed ID: 20215507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and Genomic Correlates of Neutrophil Reactive Oxygen Species Production in Pediatric Patients With Crohn's Disease.
    Denson LA; Jurickova I; Karns R; Shaw KA; Cutler DJ; Okou DT; Dodd A; Quinn K; Mondal K; Aronow BJ; Haberman Y; Linn A; Price A; Bezold R; Lake K; Jackson K; Walters TD; Griffiths A; Baldassano RN; Noe JD; Hyams JS; Crandall WV; Kirschner BS; Heyman MB; Snapper S; Guthery SL; Dubinsky MC; Leleiko NS; Otley AR; Xavier RJ; Stevens C; Daly MJ; Zwick ME; Kugathasan S
    Gastroenterology; 2018 Jun; 154(8):2097-2110. PubMed ID: 29454792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms at microRNA binding sites of Ara-C and anthracyclines-metabolic pathway genes are associated with outcome of acute myeloid leukemia patients.
    Cao HX; Miao CF; Yan L; Tang P; Zhang LR; Sun L
    J Transl Med; 2017 Nov; 15(1):235. PubMed ID: 29141648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CLAG-based induction therapy in previously untreated high risk acute myeloid leukemia patients.
    Seiter K; Ahmed N; Shaikh A; Baskind P; Liu D
    Leuk Res; 2016 Jul; 46():74-8. PubMed ID: 27151544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of genetic polymorphisms NCF4 rs1883112, CBR3 rs1056892, and ABCC1 rs3743527 with the cardiotoxic effects of doxorubicin in children with acute lymphoblastic leukemia.
    Gándara-Mireles JA; Lares-Asseff I; Reyes Espinoza EA; Blanco JG; González Font AE; Córdova Hurtado LP; Castañeda VL; Fierro IV; Romero LP; Reyes HA
    Pharmacogenet Genomics; 2021 Jul; 31(5):108-115. PubMed ID: 34096893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Azacitidine in combination with intensive induction chemotherapy in older patients with acute myeloid leukemia: The AML-AZA trial of the Study Alliance Leukemia.
    Müller-Tidow C; Tschanter P; Röllig C; Thiede C; Koschmieder A; Stelljes M; Koschmieder S; Dugas M; Gerss J; Butterfaß-Bahloul T; Wagner R; Eveslage M; Thiem U; Krause SW; Kaiser U; Kunzmann V; Steffen B; Noppeney R; Herr W; Baldus CD; Schmitz N; Götze K; Reichle A; Kaufmann M; Neubauer A; Schäfer-Eckart K; Hänel M; Peceny R; Frickhofen N; Kiehl M; Giagounidis A; Görner M; Repp R; Link H; Kiani A; Naumann R; Brümmendorf TH; Serve H; Ehninger G; Berdel WE; Krug U;
    Leukemia; 2016 Mar; 30(3):555-61. PubMed ID: 26522083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.